Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-17
1999-11-16
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514575, 546315, 548200, 548236, 548492, 548540, 549 72, 560 41, 562444, 562622, 562623, C07C25910, A61K 31165
Patent
active
059859113
ABSTRACT:
C-terminal compounds of formula ##STR1## are potent inhibitors of matrix metalloproteinase and are useful in the treatment of diseases in which matrix metalloproteinase play a role. Also disclosed are matrix metalloproteinase inhibiting compositions and a method of inhibiting matrix metalloproteinase in a mammal.
REFERENCES:
patent: 4996358 (1991-02-01), Handa et al.
patent: 5300501 (1994-04-01), Porter
patent: 5442110 (1995-08-01), Isomura et al.
Nature vol. 370 Aug. 18, 1994, pp. 555-557 "Processing of tumor necrosis factor-.alpha. precursor by metalloproteinases."
Nature vol. 370 Jul. 21, 1994, pp. 218-220 "Protection against a lethal dose of endotoxin be an inhibitor of tumor necrosis factor processing."
Nature vol. 370 Aug. 18, 1994, pp. 558-561 "Regulation of tumour necrosis factor-.alpha. processing by a metalloproteinase inhibitor."
F.B. Ibrahim, "Quantitative Determination of Oxaprozin and Several of its Related Compounds by high Performance Reversed-Phase Liquid Chromatography", J. Liq. Chromatogr., vol. 18, No. 13, (1995), 2621-2633.
Goldsmith et al., "Identification of Impurities in a Novel Antiinflammatory Oxazole Derivative", Proc. Soc. Anal. Chem., vol. 9, No. 2, (1972), pp.; 32-35.
K. Brown et al., Antiinflammatory 3-[4,5-bis (p-chlorophenyl) oxazol-2-yl] propionic acid and derivatives, Brit. 4 pp.,Addn. to. Brit. 1,206,403. (abstract).
F.W. Short et al., Synthesis of 5-aryl-2-oxazolepropionic Acids Analogs. Anti-inflammatory Agents, J. Heterocycl. Chem., vol. 6, No. 5, (1969), pp. 707-712.
Curtin Michael L.
Davidsen Steven K.
Florjancic Alan S.
Giesler Jamie R.
Guo Yan
Abbott Laboratories
Gerstl Robert
Steele Gregory W.
LandOfFree
C-terminal ketone inhibitors of matrix metalloproteinases and TN does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with C-terminal ketone inhibitors of matrix metalloproteinases and TN, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-terminal ketone inhibitors of matrix metalloproteinases and TN will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325222